ReviewACS sensors2026
Nanomaterials for In Vivo Photoacoustic Sensing: Emerging Strategies and Future Outlook.
Review in ACS sensors, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Photoacoustic imaging has emerged as a powerful modality for noninvasive, high-resolution visualization of deep tissues. The integration of smart nanomaterials is now extending PAI beyond structural imaging into functional and molecular sensing. In this perspective, we highlight recent advances in the design of stimuli-responsive nanomaterials tailored for in vivo applications, with emphasis on targeting strategies, operation in the NIR-II Window, and sensing specificity. We compare always-on versus activatable probes, summarize key molecular and microenvironmental targets such as pH, reactive oxygen species, metal ions, and enzymes, and discuss how these platforms report on disease progression and therapeutic response. We also outline emerging directions including NIR-II photoacoustic nanomaterials, PAI-guided theranostic probes, and translational pathways from chemistry to the clinic. Together, these innovations are positioning nanomaterial-enabled photoacoustic sensing as a cornerstone technology for precision diagnostics and image-guided therapy in clinical.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.